Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Trace Medical, a provider of advanced respiratory rentals and biomedical services, has made an equity investment in LiViliti ...

Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the ...

The FDA has granted 510(k) clearance to SleepRes’ KPAP-powered Kricket PAP device for the treatment of obstructive sleep ...

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

The global medical humidifier market is projected to experience a growth rate of approximately 6% over the next five years.

SleepRes, Inc., a sleep technology company focused on reimagining therapy for sleep breathing disorders, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance ...